Inhibition of fibro-intimal hyperplasia in a polytetrafluoroethylene vascular graft with standard heparin and low molecular weight heparin

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 11, 1996, Pages 764-767

  Taylor, A ^a   Fletcher, J P ^a,b   Ao, P Y ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Fibro intimal hyperplasia; Heparin; Low molecular weight heparin

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; POLITEF;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLEEDING; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CONTROLLED STUDY; END TO SIDE ANASTOMOSIS; GRAFT FAILURE; NONHUMAN; SHEEP; THROMBIN TIME;

EID: 0029859771     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb00739.x     Document Type: Article

References (30)

1. Imparato AM, Bracco A, Kim EG, Zeff R. Intimal and neofibrous proliferation causing failure of arterial reconstructions. Surgery 1972; 72: 1007-17.
2. Whittemore AD, Clowes AW, Couch NP, Mannick JA. Secondary femoropopliteal reconstruction. Ann. Surg. 1981; 193: 35-42.
3. Towne JB. Role of fibrointimal hyperplasia in vein graft failure. J. Vasc. Surg. 1989; 5: 583-4.
4. Adcock GD. Vein grafts: Implantation injury. J. Vasc. Surg. 1989; 5: 587-9.
5. Harris PL, How TV, Jones DR. Prospectively randomised clinical trial to compare in situ and reversed saphenous vein grafts for femoropopliteal bypass. Br. J. Surg. 1987; 74: 252-5.
6. Murday AJ, Gershlick AH, Syndercombe-Court YD, Mills PG, Lewis CT. Intimal thickening in autologous vein grafts in rabbits: Influence of aspirin and dipyridamole. Thorax 1984; 39: 457-61.
7. Sanz G, Pajaron A, Alegria E et al. Prevention of early aortocoronary bypass occlusion by low dose aspirin and dipyridamole. Circulation 1990; 3: 765-73.
8. Chervu A, Moore WS. An overview of intimal hyperplasia. Surg. Gynecol. Obstet. 1990; 433-47.
9. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: Pharmacological control of intimal hyperplasia - A review. J. Vasc. Surg. 1991; 6: 885-91.
10. Golden MA, Au TYP, Kirkman TR et al. Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. J Clin. Invest. 1991; 87: 406-14.
11. Norman PE, House AK. The influence of nifedipine on microvascular vein graft intimal thickening. Aust. N.Z. J. Surg. 1993; 63: 294-8.
12. Pelissou-Guyotat I, Guyotat J, Lievre M, Chignier E. Effect of nimodipine on subintimal hyperplasia of autologous vein bypass grafts in rats: A placebo-controlled study. J. Cardiovasc. Pharmacol. 1991; 17: 778-85.
13. Weigand F, Workman J, Evancho M, Schmidt S, Sharp WV. Reduction of intimal hyperplasia by calcium channel blockers in a canine interposition vein graft model. Curr. Surg. 1990; 47: 419-20.
14. Goodnight SH, Fisher M, Fitzgerald GA, Levine PH. Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis. Chest 1989; 95: 19-25S.
15. Fanelli C, Aronoff R. Restenosis following coronary angioplasty. Am. Heart J. 1990; 119: 357-68.
16. Calcagno D, Conte JV, Howell MH, Foegh ML. Peptide inhibition of neointimal hyperplasia in vein grafts. J. Vasc. Surg. 1991; 4: 475-9.
17. O'Donohue MK, Schwartz LB, Zeljko SR, Mikat EM, McCann RL, Hagen P-O. Chronic ACE inhibition reduces hyperplasia in experimental vein grafts. Ann. Surg. 1991; 214: 727-32.
18. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. J. Lab. Invest. 1985; 52: 611-16.
19. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ. Res. 1986; 58: 839-45.
20. Norman PE, House AK. Heparin reduces the intimal hyperplasia seen in microvascular vein grafts. Aust. N.Z. J. Surg. 1991; 61: 942-8.
21. Wilson NV, Salisbury JR, Kakkar VV. Effect of low molecular weight heparin on intimal hyperplasia. Br. J. Surg. 1991; 78: 1381-3.
22. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265: 625-6.
23. Dryjski M, Mikat E, Bjornsson TD. Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid. J. Vasc. Surg. 1988; 8: 623-33.
24. Sumpio BE. Mechanical stress and cell growth. J. Vasc. Surg. 1989; 10: 570-1.
25. LoGerfo FW. Biomechanics of prosthetic graft failure. J. Vasc. Surg. 1989; 10: 581-2.
26. Watase M, Kambayashi J, Itoh T et al. Ultrastructural analysis of pseudo-intimal hyperplasia of polytetrafluoroethylene prosthesis implanted into the venous and arterial systems. Eur. J. Vasc. Surg. 1992; 6: 371-80.
27. Clowes AW, Clowes MM. Inhibition by heparin of smooth muscle hyperplasia. J. Vasc. Surg. 1989; 10: 589-91.
28. Angelini GD, Soyombo AA, Newby AC. Smooth muscle cell proliferation in response to injury in an organ culture of human saphenous vein. Eur. J. Vasc. Surg. 1991; 5: 5-12.
29. Mestre M, Clairefond P, Mardiguian J, Trillou M, LeFur G, Uzan A. Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis. Thromb. Res. 1985; 38: 389-99.
30. Mestre M, Uzan A, Sedivy P, Cavero I. Enoxaparine (Clexane, Lovenox), a low molecular weight heparin, enhances t-PA-induced coronary thrombosis lysis in anaesthetised dogs without inducing hypocoaguability. Thromb. Res. 1992; 66: 191-206.